Et- årige overlevelsesskøn var tilsvarende i undergruppen af patienter med PAH sekundært til bindevævssygdom for gruppen behandlet med Thelin (98%).
One-year survival estimates were similar in the subgroup of patients with PAH secondary to connective tissue disease for the Thelin treated group (98%).